Head-to-head comparison
Fitish vs HealthSource
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Oral-capable, LegitScript-verified, and nationwide — trust signals are strong, but pricing sits mid-to-high.
$219/mo sema · $339/mo tirz
Marked down on: Higher pricing than the value leaders
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Desk Score
HealthSource sells compounded semaglutide, compounded tirzepatide and a nightly sublingual tirzepatide tablet in all 50 states, charged every four weeks rather than by the calendar month.
$199 per 4 weeks sema · $299 per 4 weeks tirz · Verified August 2026
Marked down on: You pay before the medical intake — the questionnaire link appears only after checkout, and withdrawing once you have filled it in costs you $25–$45 for the provider review
Fitish takes this head-to-head with the higher Desk Score, 86/100 (B) against 84/100 (B) for HealthSource. HealthSource still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Fitish
86/100
B
HealthSource
84/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Fitish | HealthSource |
|---|---|---|
| Semaglutide | $219/mo$219/mo | $199 per 4 weeks$199 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Tirzepatide | $339/mo$339/mo | $299 per 4 weeks$299 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who prioritize a verified pharmacy and oral options over finding the lowest rate. | Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks. |
| Desk Score | 86/100B | 84/100B |
The verdict
Desk pick — FitishFitish takes this head-to-head with the higher Desk Score, 86/100 (B) against 84/100 (B) for HealthSource. HealthSource still holds its ground where its strengths line up with yours.
Choose Fitish if…
People who prioritize a verified pharmacy and oral options over finding the lowest rate.
$219/mo sema · $339/mo tirz · All 50 states
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Choose HealthSource if…
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
$199 per 4 weeks sema · $299 per 4 weeks tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Fitish · HealthSource.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Fitish
- CoreAge Rx vs HealthSource
- Curex vs Fitish
- Curex vs HealthSource
- BetterMe Rx vs Fitish
- BetterMe Rx vs HealthSource
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.